skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Colon and Rectal Cancer: Treatment
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
October is Breast Cancer Awareness Month

NCI Annual Progress Report on Cancer Research 2003

Women, Tobacco and Cancer: Agenda for 21st Century

Past Highlights
Need Help?
Treatment Information
Colon Cancer (PDQ®): Treatment
     [ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of colon cancer.

Rectal Cancer (PDQ®): Treatment
     [ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of rectal cancer.

FDA Approves Avastin as First Angiogenesis Inhibitor for Colorectal Cancer
Avastin (bevacizumab), is the first angiogenesis inhibitor approved to treat colorectal cancer that has spread to other parts of the body.

Bevacizumab (Avastin™) Improves Survival in Metastatic Colorectal Cancer
Patients with newly diagnosed metastatic colon cancer who received the therapeutic agent bevacizumab (Avastin™) along with the chemotherapy combination known as IFL had substantially longer overall survival times than patients who received IFL but with a placebo instead of bevacizumab. With these results, bevacizumab becomes the first anti-angiogenesis agent to prove effective in a randomized Phase III trial.

FDA Approves Erbitux for Colorectal Cancer
Erbitux (cetuximab) is the first monoclonal antibody approved to treat patients with advanced colorectal cancer that has spread to other parts of the body.

Oxaliplatin-Based Regimen Prolongs Survival After Colorectal Cancer Surgery
The oxaliplatin-based chemotherapy combination known as FOLFOX significantly improved disease-free survival compared to 5-FU and leucovorin when used as adjuvant therapy (after surgery) in patients with stage II and stage III colorectal cancer.

Older Patients with Colon Cancer Benefit from Chemotherapy
Adjuvant (additional) chemotherapy for colon cancer is equally effective and no more toxic in otherwise healthy patients age 70 and older than in younger patients, according to research published in the October 11, 2001, issue of New England Journal of Medicine.

Angiogenesis Inhibitors in the Treatment of Cancer
A fact sheet that describes the process of eliminating the blood supply to tumors. Lists the cancers in which this approach is being tested.

Angiogenesis Inhibitors
A collection of material about a group of compounds called angiogenesis inhibitors.

Biological Therapies for Cancer: Questions and Answers
A fact sheet that provides an overview of how the immune system functions and describes the actions of available biological therapies.

Radiation Therapy for Cancer: Questions and Answers
A fact sheet that defines the different types of radiation therapy and discusses scientific advances that improve the effectiveness of this treatment.

Targeted Cancer Therapies: Questions and Answers
A fact sheet that describes types of targeted cancer therapies which use drugs to interfere with cancer cell growth and division.

Metastatic Cancer: Questions and Answers
A fact sheet about the diagnosis and treatment of cancer that has spread.
skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov